CAMBRIDGE, MA—Mersana Therapeutics, Inc. (NASDAQ:MRSN), a biotech firm with a market capitalization of $76.22 million, just lately disclosed a collection…
By David Shepardson WASHINGTON (Reuters) - Outgoing U.S. President Joe Biden will signal an government order on Sunday geared toward…
Investing.com-- The U.S. greenback's current power could falter as key indicators recommend it's overbought, BCA Analysis analysts stated in a…
By Lananh Nguyen DAVOS, Switzerland (Reuters) - Financial fears have escalated into grievances amongst 60% of individuals, with many believing…
Investing.com -- The $TRUMP memecoin, which had been a sensation over the weekend, skilled a 36% drop in worth mid-day…
CAMBRIDGE, MA—Mersana Therapeutics, Inc. (NASDAQ:MRSN), at the moment buying and selling close to its 52-week low of $0.56, lately disclosed…
By Sheila Dang and Jaspreet Singh (Reuters) -TikTok stopped working for 170 million Individuals late on Saturday after the U.S.…
Investing.com -- The cryptocurrency market is in a stir following the launch of Donald Trump's $TRUMP meme coin, which noticed…
Investing.com - EOS was buying and selling at $0.8136 by 17:49 (22:49 GMT) on the Investing.com Index on Sunday, down…
In latest transactions disclosed by Mersana Therapeutics, Inc. (NASDAQ:MRSN), Timothy B. Lowinger, the corporate's Senior Vice President and Chief Science…